Financials in USD. Standardized financial statements.
A compact view of how SpectrumDNA, Inc. turns revenue into operating income and net income.
| Metric | FY 2010 | FY 2009 | FY 2008 | FY 2007 |
|---|---|---|---|---|
| Revenue? | $141,250 | $149,800 | $67,747 | $53,952 |
| Revenue Growth? | -5.7% | +121.1% | +25.6% | 0.0% |
| Cost of Revenue? | $4,083 | $68,926 | $97,669 | $43,949 |
| Gross Profit? | $137,167 | $80,874 | -$29,922 | $10,003 |
| Gross Margin? | +97.1% | +54.0% | -44.2% | +18.5% |
| Operating Expenses? | $2.06M | $2.46M | $2.57M | $1.92M |
| Operating Income? | -$1.92M | -$2.38M | -$2.60M | -$1.91M |
| EBITDA? | -$1.90M | -$2.34M | -$2.46M | -$1.87M |
| Income Before Tax | -$1.97M | -$2.43M | -$2.56M | -$1.83M |
| Income Tax Expense | $0 | $66,873 | $0 | $0 |
| Net Income? | -$1.97M | -$2.43M | -$2.56M | -$1.83M |
| EPS? | $-0.03 | $-0.05 | $-0.05 | $-0.04 |
| Diluted EPS? | $-0.04 | $-0.05 | $-0.05 | $-0.04 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality